Searching map area
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer
? TBD
scientific article published on 30 August 2010
Nobody has rated this yet. Be the first!
Lists 0
Instance of
Subject
References